1 Min Read
Sept 21 (Reuters) - Paratek Pharmaceuticals Inc
* Paratek Pharmaceuticals Inc - its antibiotic omadacycline has been granted additional qualified infectious disease product designation by U.S. FDA Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.